Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Senseonics holds a “Moderate Buy” consensus from six analysts, with four buys, one hold and one sell; the average 12-month price target is $17.20.
• Analysts have recently lowered their price targets, including HC Wainwright to $14 and Stifel to $8, while maintaining respective buy and hold ratings.
• The company remains unprofitable: Senseonics reported a quarterly loss of $0.63 per share versus the expected $0.55 loss, and analysts anticipate a full-year loss of $2.41 per share.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $17.20.

Several equities research analysts recently issued reports on the stock. HC Wainwright decreased their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating on the stock in a research report on Tuesday, May 12th. Stifel Nicolaus decreased their price target on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, May 11th. Mizuho lowered their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating for the company in a research note on Wednesday, July 15th. Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a report on Saturday. Finally, Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Tuesday, July 28th.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

Several institutional investors and hedge funds have recently added to or reduced their stakes in SENS. J.Safra Asset Management Corp purchased a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $636,000. Kestra Advisory Services LLC acquired a new stake in Senseonics Holdings, Inc. Common Stock in the 1st quarter valued at $68,000. GSK plc purchased a new position in Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at about $60,000. State of Wyoming purchased a new position in Senseonics Holdings, Inc. Common Stock in the second quarter valued at about $67,000. Finally, Cetera Investment Advisers acquired a new position in shares of Senseonics Holdings, Inc. Common Stock during the first quarter worth about $85,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

More Senseonics Holdings, Inc. Common Stock News

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

• Positive Sentiment: HC Wainwright reiterated a Buy rating and a $14 price target for Read More., implying substantial upside if the company’s long-term growth plans materialize.
• Positive Sentiment: The analyst’s estimates show losses narrowing over time, from an expected $2.41 per-share loss in fiscal 2026 to $0.60 in fiscal 2030. That projected improvement may be encouraging to investors focused on eventual profitability.
• Neutral Sentiment: Reported short interest was listed at zero shares, with a zero-day days-to-cover ratio. Because the figures show no measurable short position and the reported percentage change is not meaningful, the data provides little actionable signal for the stock.
• Negative Sentiment: HC Wainwright lowered its fiscal 2026 EPS forecast to a $2.41 loss from a $2.23 loss and cut its fiscal 2027 forecast to a $2.05 loss from $1.97. Estimates were also reduced for fiscal 2028, 2029 and 2030.
• Negative Sentiment: Near-term projections weakened as well: expected third-quarter 2026 EPS was reduced to a $0.58 loss from $0.54, while fourth-quarter 2026 EPS was lowered to a $0.52 loss from $0.48. The revisions reinforce that Senseonics remains unprofitable and could face pressure before its longer-term outlook improves.

Senseonics Holdings, Inc. Common Stock Stock Up 4.4%

Shares of NASDAQ:SENS opened at $7.87 on Wednesday. The stock has a market capitalization of $328.97 million, a P/E ratio of -3.53 and a beta of 1.01. The firm has a fifty day simple moving average of $5.89. Senseonics Holdings, Inc. Common Stock has a 52 week low of $4.79 and a 52 week high of $11.58. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The business had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. Sell-side analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.41 earnings per share for the current fiscal year.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source